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Autophagy is a homeostatic process that is highly conserved across different types of mammalian cells. Autophagy is able to relieve
tumor cell from nutrient and oxidative stress during the rapid expansion of cancer. Excessive and sustained autophagy may lead
to cell death and tumor shrinkage. It was shown in literature that many anticancer natural compounds and extracts could initiate
autophagy in tumor cells. As summarized in this review, the tumor suppressive action of natural products-induced autophagy
may lead to cell senescence, provoke apoptosis-independent cell death, and complement apoptotic cell death by robust or target-
specificmechanisms. In some cases, natural products-induced autophagy could protect tumor cells from apoptotic death. Technical
variations in detecting autophagy affect data quality, and study focus should be made on elaborating the role of autophagy in
deciding cell fate. In vivo study monitoring of autophagy in cancer treatment is expected to be the future direction. The clinical-
relevant action of autophagy-inducing natural products should be highlighted in future study. As natural products are an important
resource in discovery of lead compound of anticancer drug, study on the role of autophagy in tumor suppressive effect of natural
products continues to be necessary and emerging.
1. Introduction
Accumulating studies have revealed the role of autophagy
as an important cellular homeostatic process. Autophagy,
derived fromGreek meaning self-eating, is a self-degradative
approach to clear intracellular organelles and proteins [1].
It was first coined by Deter and de Duve in 1960s, with
observation that subcellular organelles like mitochondria
could be degraded in lysosome of perfused rat liver [2].
Physiologically, autophagy is highly conserved across types
of mammalian cells and works in housekeeping manner
to scavenge misfolded proteins and damaged organelles, as
well as infections [3]. This process is critical for energy bal-
ance and genome stability of cells. Autophagy could recycle
the nonessential long-term proteins to generate energy in
response to nutrient deficiency in starved cells [4]. In general
speaking, autophagy is a machinery of cell survival that
serves to conquer different types of cellular stress, which may
subsequently result in cell death. However, studies in recent
years rediscovered autophagy as a mechanism of nonapop-
totic cell death, as sustained autophagy may excessively
degenerate intracellular structures, and cells undergoing
uncontrolled autophagy eventually vanish [5]. It is a mor-
phological definition and no conclusive evidence of specific
mechanisms underlying autophagy-induced cell death could
be observed [6]. Aberrancy or deficiency of autophagy was
observed in various kinds of human disorders such as
cardiomyopathy, diabetes, neurodegeneration, autoimmune
diseases, infections, liver diseases, and cancers.
It was particularly found that the role of autophagy in
human cancer is complicated. On one hand, autophagy may
be critical in removing stress induced by infection, hypoxia,
nutrient deprivation, and metabolic damage. Autophagy-
deficient cells are much susceptible to stress and damage to
cell genome, leading to easier tumorigenesis in vivo. It was
found that chemical carcinogen-induced hepatocarcinoma
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could be suppressed by enhanced autophagy which removed
aggresome and damaged organelles that could lead to DNA
double strand break and genome instability [7], while mice
with Beclin-1 knockout are tumor prone [8]. Overexpression
of Beclin-1 in mice could develop excessive autophagy to
prevent tumor development [9]. On the other hand, acti-
vation of autophagy in tumor cells is found to promote
tumor development. As tumor cells expand so quickly that
nutrients and oxygen could not be sufficiently supplied,
tumor cells may undergo serious starvation that causes cell
stress. Autophagy in tumor cells is therefore carried out
to maintain cell survival by complementing energy supply
to conquer nutrient deficiency, and it could remove the
damaged organelles and proteins under hypoxia condition
[10]. It was observed that inhibition of autophagy led to tumor
regression and extended survival of xenografted mice of
pancreatic cancer model [11]. However, autophagy may con-
tribute to tumor cell death, in a robust or target-specific way,
in cytotoxic agents-treated cancer cells [12]. In recent years,
accumulating studies have shown that natural compounds
and extracts isolated from medical plants with anticancer
property could regulate autophagy in human cancer cells.
Phenols, alkaloids, flavones, and organic acids are reported
to be autophagy regulators, and it was shown that autophagy
may play either cytoprotective or cytotoxic role in natural
products-treated cancer cells. With a great interest of finding
lead compounds of potential anticancer drug from natural
compounds, whose mechanism of action involves autophagy
regulation, we summarized the recent advance in studying
natural autophagy regulators and discussed the achievements
and artifact of the state of the art.
2. Natural Products-Induced
Autophagy in Cancer
Data was retrieved from publications regarding the regula-
tory action of natural products on autophagy in cancer cells.
Interestingly, almost all the literature refers to the property
of natural products in inducing autophagy in cancer. Few
studies reported inhibition of autophagy by natural products.
Kallifatidis et al. reported that a marine natural compound
manzamine A could suppress autophagy in pancreatic cancer
cells. Manzamine A could block the fusion of autophago-
some and lysosome and abrogate autophagosome turnover
[13]. Despite the fact that manzamine A exhibits potent
antitumor activity, no direct experimental evidence could
show that inhibition of autophagy could contribute to tumor
suppression. A recent study revealed that oblongifolin C
from Garcinia yunnanensis Hu could suppress autophagy
and enhance the antitumor effect of nutrient deprivation.
As cancer cell develops autophagy as adaptive mechanism
towards nutrient deprivation, inhibition of autophagy may
lead to death of the cells [14]. However, studies reporting
natural products-induced autophagy elaborated more details
on the role of autophagy in mediating inhibition of cancer by
these compounds (Tables 1 and 2).
2.1. Natural Product-Induced Autophagy as
a Tumor Suppressor
2.1.1. Autophagy That May Result in Cancer Cell Senescence.
Previous studies have revealed that natural products may
induce autophagy and cell cycle arrest in cancer cells without
significant presentation of cell death. Natural compound
isolated from Radix Ophiopogon Japonicus named ophio-
pogonin B could induce both G0/G1 cell cycle arrest and
autophagy in lung cancer cells, without significant apoptosis
observed [15]. Sustained arrest of cell phase contributes to
cell senescence, during which proliferation rate of cancer
cells reduces andmotility and invasivenessmight be retarded.
Pedro and colleagues reported that seven natural prenylated
flavones may initiate autophagy in ER positive breast cancer
cells while DNA synthesis was suppressed. The proliferation
of cancer cells was reduced, though there was no evidence
that could directly link up autophagy initiation with prolifer-
ation inhibition [16]. Kaushik et al. showed that natural com-
pound honokiol may cause proliferation inhibition which is
associated with autophagy and cell cycle arrest [17]. Evidence
showing interaction between autophagy and cell cycle arrest
is not very clear though some efforts have been made and
found that redistribution of cell cycle phase may result
from autophagy initiation. Ko et al. showed that autophagy
induction may be associated with proliferation inhibition by
natural product in cancer cells. In colon cancer cells treated
with dimethyl cardamonin isolated from Syzygium sama-
rangense (Blume) Merr. & L.M. Perry (Myrtaceae), presence
of autophagy inhibitor 3-MA or siRNA against Beclin-1 or
Atg5 could restore proliferation of tumor cells [18]. A natural
compound penta-1,2,3,4,6-O-galloyl-beta-D-glucose (PGG)
may in parallel induce both autophagy and cell cycle arrest.
Inhibition of autophagy by the presence of chemical inhibitor
or RNA interference in PGG-treated cancer cells results in
reentering of cell cycle, suggesting the role of autophagy in
mediating cancer cell senescence [19]. However, we cannot
simply rule out the possibility that autophagymay be induced
due to arrest of cell cycle. Law showed that Alisol B isolated
from Alisma orientale could initiate cell cycle redistribution
and autophagy. Blockade of autophagy in Alisol B-treated
cancer cells may result in unfolded protein accumulation-
related endoplasmic reticulum stress [20], which indicated
that autophagy was initiated to scavengemisfolded protein in
Alisol B-treated cancer cells. The accumulation of misfolded
protein might be associated with abnormal arrest of cell
cycle and aberrant distribution of protein expression profile.
In this case, induction of autophagy might be initiated to
maintain cell under cell phase arrest conditions by clearing
cellular stress. This was further evidenced by the observation
that a natural compound Cucurbitacin B could initiate
autophagy to conquer nutrient stress induced by DNA
damage-associated G2/M cell cycle arrest [21]. As retrieving
molecules that could specifically facilitate reentering of cell
cycle are hardly obtained, evidence of cell cycle arrest-
induced autophagy may not be straightforward and further
investigation is still required.
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Table 1: Natural products that induce tumor suppressing autophagy.
Compound Plant of origin Pathway involved Reference
2-Methoxyestradiol Brassica oleracea var. botrytis N.A. [22]
Akebia saponin PA Dipsacus asperoides JNK, caspase-3 activation↑ [23]
Alisol B Alisma orientale CaMKK-AMPK-mTOR↑ [20]
Baicalin Scutellaria baicalensis Georgi Akt↓ [24]
Berberine Coptidis Rhizoma Akt/mTOR, CD147↓;Beclin-1, p38 MAPK↑
[25, 26]
Bufalin Toad venom ROS, JNK, Atg, Beclin-1, TNF, Atg8↑ [27, 28]
Caffeine Coffee beans Erk1/2↑;P70S6K, S6, 4E-BP1, Akt↓
[29]
Celastrol Tripterygium wilfordii LC3-II, MAPK, Beclin-1↑;Akt, mTOR, S6K, MEK↓
[30, 31]
Coibamide A Marine cyanobacterium N.A. [32]
Crotoxin South American rattlesnake N.A. [33]
Curcumin Curcuma longa Erk1/2, Beclin-1, LC3-II, AMPK↑;Akt/mTOR/p70S6K↓
[34–38]
Dimethyl cardamonin Syzygium samarangense (Blume) Merr. &L.M. Perry (Myrtaceae) N.A.
[18]
Evodiamine Evodia rutaecarpa Bcl-2/Beclin-1↓ [39]
Fangchinoline Radix Stephaniae tetrandrae AMPK, sestrin2, p53 translocation↑ [40]
Flavokawain B Alpha pricei Hayata N.A. [41]
Furanodiene Rhizoma curcumae N.A. [42]
Gambogenic acid Gamboge Beclin-1↑ [43]
Honokiol Officinal Magnolia Bark Beclin-1↑;Akt/mTOR↓
[17, 44]
Indirubin Isatis indigotica Fort. N.A. [45]
Jia-Wei-Xiao-Yao-San N.A. N.A. [46]
KIOM-C N.A. JNK, ROS, CHOP↑ [47]
Liensinine, isoliensinine,
dauricine, cepharanthine N.A.
AMPK↑;
mTOR↓
[48]
Magnolol Officinal Magnolia Bark Bax/Bcl-2 ratio↑ [49]
Matrine Radix Sophorae flavescentis Endosome/lysosome pH value↑ [50]
Neferine Nelumbo nucifera ROS↑;GAH, PI3K/Akt/mTOR↓
[51]
Neoalbaconol Albatrellus confluens PDK1, PI3K, Akt, HK2↓,glucose consumption, ATP↓
[52]
Nexrutine Phellodendron amurense N.A. [53]
Oblongifolin C Garcinia yunnanensisHu Lysosome cathepsin↓ [14]
Oleifolioside B Dendropanax morbifera Leveille Atg3, LC3-II↑;Nrf2↓
[54]
Ophiopogonin B Radix Ophiopogon Japonicus pAkt/mTOR/p70S6K↓ [15]
Oyaksungisan (OY) N.A. JNK↑ [55]
Penta-1,2,3,4,6-O-galloyl-
beta-D-glucose
(PGG)
N.A. Unfolded protein response,MAPK8/9/10↑
[19]
Pheophorbide-a Scutellaria barbata Erk↓ [56]
Piperlongumine Piper longum L. ROS, p38 MAPK↑ [57]
Plumbagin Plumbago zeylanica PI3K/Akt/mTOR↓ [58]
Riccardin D Dumortiera hirsuta Caspases cleavage↑ [59]
Rottlerin Mallotus philippinensis N.A. [60]
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Table 1: Continued.
Compound Plant of origin Pathway involved Reference
Saikosaponin-D N.A.
ER stresses, unfolded protein response,
cytosolic calcium, AMPK↑;
sarcoplasmic/endoplasmic reticulum
Ca(2+) ATPase pump↓
[61]
Samsoeum N.A. AMPK, Erk, Beclin-1, LC3-II↑;Akt, mTOR↓
[62]
Solanum nigrum leaves
extract N.A. N.A.
[63]
Stellettin A Geodia japonica ER stresses↑ [64]
Tanshinone IIA Salviae miltiorrhizae Erk↑ [65]
Tetrandrine Radix Stephaniae tetrandrae N.A. [66]
Timosaponin AIII Anemarrhena asphodeloides AMPK↑;XIAP, mTOR↓
[67]
Triterpenes Ganoderma lucidum Beclin-1↑;p38 MAPK↓
[68]
Ursolic acid Bupleurum falcatum L. (Umbelliferae) JNK↑ [69]
Viriditoxin Jellyfish Nemopilema nomurai LC3-II, Atg5, Atg7, Beclin-1↑ [70]
Vitexin 6 Byrsonima crassifolia N.A. [71]
Voacamine Peschiera fuchsiaefolia N.A. [72]
Weikang Keli
Root of Codonopsis pilosula, Rhizoma
Atractylodis Macrocephalae, Rhizoma
Curcumae Aeruginosae, Rhizoma
Pinelliae, Actinidia chinensis Planch, and
Rhodiola rosea
N.A. [73]
Table 2: Natural compounds that induce cytoprotective autophagy.
Compound Plant of origin Pathways involved Reference
𝛼-Eleostearic acid Momordica charantia Akt↓, Erk1/2↑ [74]
Anthricin Anthriscus sylvestris (L.) Hoffm. Akt/mTOR↓ [75]
Arenobufagin Toad venom PI3K/Akt/mTOR↓ [76]
𝛽-Elemene Zedoary Atg5↑, Akt/mTOR↓, Erk1/2↓ [77–79]
Bufalin Toad venom LC3-II↑, Beclin-1↑, Atg7↑, Atg12↑,AMPK↑, mTOR↓ [80, 81]
Crotoxin South American rattlesnake Not applicable (N.A.) [33]
Cucurbitacin I Cucumis sativus L. Beclin-1↑,Beclin-1/Bcl-2 interaction, HIF-1𝛼↓ [82]
Dioscin Soybean N.A. [83]
Englerin A Phyllanthus engleri Akt↓, Erk↓, AMPK↑ [84]
Gossypol Cotton seeds Interaction between Bcl-2 and Beclin-1↓ [85]
Isobavachalcone Fructus psoraleae N.A. [86]
Mollugin Rubia cordifolia L. Erk↑PI3K/Akt/mTOR↓ [87]
Parthenolide Feverfew AMPK↑ [88]
Physalin A Physalis alkekengi L. var. franchetii(Mast.) Makino Beclin-1↑ [89]
Resveratrol Japanese knotweed Erk1/2↑, p38 MAPK↑, Atg5↑, Beclin-1↑,LC3-II↑, Akt/mTOR↓, [90–92]
Sesbania grandiflora
flowers N.A. N.A. [93]
Wogonin Scutellaria baicalensis mTOR↓, Raf/Erk1/2↓ [94]
Zearalenone Fusarium graminearum LC3-II, Beclin-1 [95]
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2.1.2. Autophagy as an Exclusive Mechanism of Cell Death.
Although many studies have reported that autophagy may
be initiated for killing the cells, there is lack of evidence that
can be markers and mechanisms of presence of autophagic
cell death (ACD). The existence of ACD is therefore under
constant criticism, as autophagy is generally observed in
dying cells. In this case, autophagy in dying cells may
be considered as an automatically raised mechanism for
cell survival, even though it is not effective enough to
overcome the cellular stress-induced death [5]. Hau et al.
reported that coibamideA, a compound isolated frommarine
Cynabacterium could initiate both apoptosis and autophagy
while autophagy may not be essential for cell death or
survival, as initiation of autophagy likely occurred in dying
cells in response to coibamide A treatment [32]. However,
existence of ACD cannot be simply ruled out as many
studies have shown that natural products could lead to cell
death exclusively with presence of autophagy. Aoki et al.
showed that curcumin could initiate autophagy in cancer
cells while no apoptosis could be detected, and induction
of autophagy is associated with cell death [34]. However, it
is contradicting to observe that suppression of autophagy
in curcumin-treated cell initiated apoptosis and enhanced
cytotoxicity. Autophagy is therefore likely to be a combined
mechanism of both cell death and survival. In another
study, Meschini and colleagues found that voacamine from
Peschiera fuchsiaefolia induced tumor cell death dependent
on autophagy but not apoptosis [72]. Similar observation was
got in other natural products-treated cancer cells including
bufalin [28] and triterpenes [68]. The criteria to rule out the
presence of apoptosis are pivotal for identifying autophagy
as an exclusive mechanism of inducing cell death. Liu and
colleagues reported that stellettin A from Geodia japonica
could induce autophagy as they could observe neither the
altered expression of apoptosis marker Bcl-2 nor the appear-
ance of apoptotic nuclei [64]. However, it is not sufficient to
conclude with such simple observation on Bcl-2 expression
as apoptosis can be initiated by many other pathways. Study
fromour group introduced a variety ofmarkers to exclude the
presence of apoptosis in fangchinoline-treated hepatocellular
carcinoma cells, including presentation of Annexin V on
dying cells, fragmentation of cell DNA, and cleavage of
caspases [40]. Further evidence of nonapoptotic death was
obtained to observe that fangchinoline induced cell death
was not attenuated by caspase inhibitor. Xie et al. reported
in similar way that bufalin-induced colon cancer cell death
is independent of caspase activation [27]. As caspases are
much exclusively necessary to apoptotic cell death, natural
product may have differential mechanisms in inducing cell
death in caspase-3-proficient and caspase-3-deficient MCF-7
cells. Rottlerin could induce both apoptosis and autophagy in
caspase-3-proficient cells, while in caspase-3-deficient cells,
it can only initiate autophagy that was associated with cell
death [60]. Furthermore, the exclusiveness of autophagy as
mechanism of cell death may be determined in the presence
of caspase inhibitor.Wang et al. measured autophagy induced
by piperlongumine from Piper longum L. in the presence
of caspase and necrosis inhibitors. It was found that cell
death was attenuated when autophagy inhibitor was added to
piperlongumine-treated cancer cells [57]. Observation of this
study may confirm that cell death caused by piperlongumine
resulted from autophagy induction. Nonetheless, in some
cases, apoptosis still could be activated to induce caspases
independently [96]. To gain more reliable conclusion, Wong
et al. examined autophagic cell death induced by natural
compound saikosaponin-D in apoptosis-defective cells [61].
The use of apoptosis-defective cells might be quite self-
explanatory but authentication and identification of the cell
lines are critical for data interpretation.
2.1.3. Autophagy That Plays a Supportive Role in Apoptosis.
As autophagy is usually observed in dying cells, argument
was raised to criticize the role of autophagy in promoting cell
death, which claimed that autophagy might be an accompa-
nying event that occurs after initiation of apoptosis. Despite
the fact that the argument appears to be reasonable since
autophagy could be regarded as a mechanism to scavenge
dysfunctional organelles and proteins during apoptosis, some
studies indeed observed that autophagy may contribute
to supporting apoptosis. It was massively considered that
autophagy may play a supportive role in inducing cell death
though Xavier and colleagues found that, in ursolic acid-
induced cell death, apoptosis only contributes to a small
proportion while autophagic cell death may be the mass
[69]. Saiki et al. showed that, in autophagy-deficient cells,
induction of apoptosis by caffeine was attenuated [29]. In
most literature apoptosis was found to take the leading role.
Xiao et al. found that natural compound curcumin could
induce both apoptosis and autophagy, while inhibition of
autophagy with small molecule inhibitor 3-MA results in
reduced cell death [38]. As a simply obtained autophagy
inhibitor, 3-MA was widely used in the studies which would
like to distinguish autophagy cell death from apoptosis.
Natural compound riccardin D was reported to cause cancer
cell death with both apoptosis and autophagy, which could
be reduced by presence of 3-MA [97]. A herbal formula
Oyaksungisan was found to initiate autophagic cell death
while cotreatment of 3-MA rescued the tumor cell [55].
Although these studies may preliminarily try to distinguish
cell death induced by autophagy from apoptosis, the use of
3-MA is under criticism as it was found that 3-MA could
also block apoptosis. This may lead to overestimation on
proportion of cell death induced by autophagy. Another
autophagy inhibitor bafilomycin A1 was introduced in some
other studies to gain more accurate results. Bafilomycin
A1 retards the fusing of autophagosome and lysosome and
as a result abrogates autophagy process. Jia et al. used
bafilomycin A1 to inhibit autophagy induced by curcumin
in leukemia cells and showed that cell death was attenuated
in the presence of bafilomycin A1. The results are more
compelling but still cannot rule out any nonspecific action of
bafilomycinA1, which survives the cells. A better understand-
ing may be obtained if genetic suppression of autophagy-
related proteins such as Atg5 could be introduced. Qiu et
al. inhibit autophagy both pharmacologically and genetically
to show that autophagy contributed to tetrandrine-induced
cell death in human cancer [66]. Berberine was shown to
induce both autophagy and apoptosis in hepatoma [26], and
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study from our laboratory measured the proportion that
autophagy contributes to cell death induced by berberine. By
introducing 3-MA and RNA interference against Atg5, we
found that autophagymay contribute to about 10%of the total
cell death in berberine’s action [25].This solution seemsmuch
reliable, despite the fact that some recent studies also found an
autophagy-independent function of Atg5 in triggering death
of cell [98]. Knockdown of one more essential protein in
autophagy pathway may possibly improve accuracy in tech-
nical way. Solution may be also available to examine the time
course of autophagy in dying cells. Evodiamine from Evodia
rutaecarpa could trigger cell death with both autophagy and
apoptosis, while the presence of 3-MA reduced the number
of dead cells [39]. The induction of apoptosis and autophagy
looks parallel in time course, which indicates that autophagy
might not just serve as a scavenger after apoptotic cell death
is initiated by evodiamine.
Theotherway bywhich autophagymay support apoptosis
in dying cells with apoptosis is much interesting. Xu et al.
examined the relationship between autophagy and apoptosis
induced by Akebia saponins PA from Dipsacus asperoides.
When AGS cells were cotreated with autophagy inhibitor
bafilomycin A1, the Akebia saponins A1-triggered caspase-3-
dependent apoptosis was decreased; however, autophagy was
not affected in cells with caspase-3 inhibitor [23]. Induction
of apoptosis in this case was possibly autophagy-dependent.
Similar observation was obtained in bufalin-treated liver
cancer cells [99]. Since apoptosis is regarded to be critically
controlled but autophagy is generally much more robust
process, it is not likely that less fine-tuned autophagy could
particularly target proteins that tightly regulate apoptosis
pathways. However, recent studies have revealed autophagy
may mediate degradation of some particular proteins. This
kind of autophagy requires binding of chaperons to help
recognition of autophagosome to the targeted protein and
therefore was given a term as chaperon-mediated autophagy
(CMA) [100]. The mechanism of natural products-induced
CMA is not fully addressed; however, study from our labo-
ratory showed that, in timosaponin AIII-induced apoptosis,
autophagy may be essential to cause degradation of intra-
cellular inhibitor of apoptosis, XIAP protein. Suppression of
XIAP was sufficient to trigger apoptosis in hepatocellular
carcinoma. And while autophagy was reduced, apoptosis
could not be programmed and timosaponinAIII-treated cells
would undergo necrosis instead [67].
2.2. A Protective Role of Natural Products-Induced Autophagy
on Cancer Cells. Theprotective effect of autophagy in natural
products-induced cancer cell death could be much more
straightforward as the process was naturally regarded as cel-
lular stress clearance. Table 2 listed out compounds that have
been reported to initiate a protective autophagy in cancer
cells, among which resveratrol is most frequently studied.
Resveratrol was found to trigger cytoprotective autophagy
in both glioma and melanoma cells [90–92]. Retrieved data
reveal that cytoprotective autophagy initiated by natural
products was always present with apoptosis. This is not
surprising since apoptosis and autophagy may be regulated
by some common proteins and signaling. The antiapoptotic
Bcl-2 protein is the typical one whose expression may be
reduced to trigger apoptosis. Moreover, absence of Bcl-2
could release Beclin-1 to initiate autophagosome formation
and as a result both apoptosis and autophagy are induced
[101]. The herbal extract Samsoeum (SSE) was shown to
trigger both apoptosis and autophagy in cancer cells with
reduced expression of Bcl-2 while with an increase in Beclin-
1 [62]. Similar observation was obtained in cells treated
with methanolic fraction of bitter melon extract [102]. The
Akt/mTOR pathway, which is aberrantly activated in cancer,
may be another molecular mechanism of crosstalk inter-
connecting apoptosis and autophagy [103]. While inhibition
of Akt triggers cell apoptosis and reduces survival, the
subsequent mTOR suppression could initiate autophagy in
cells [104]. In this case, natural inhibitors of Akt pathway
may be able to induce both apoptosis and autophagy in one
cell (Table 2). Data interpretation is much easier as it is not
quite difficult to identify the protective role of autophagy
technically; however, quantitative measurement on the pro-
tection is still problematic, since till now no inhibitor could
specifically and efficiently block autophagy in cells. This may
lead to either overestimating or underestimating the action of
cytoprotective autophagy.
3. Discussion
3.1. Monitoring a Real Autophagy: A Technical Issue. As a
dynamic intracellular process, autophagy is composed of
an onset activity, during which autophagosome is formed
and fused with lysosome, and an offset activity that facili-
tates degradation of autophagosome-lysosome complex (also
called autolysosome) [105]. Although some major events
could be monitored as biomarkers of autophagy, it is far
from being accurate to draw any conclusion with only one
or two events observed. We are quite sure that the criteria are
improving with time; as a result, conclusion from some early
literature reporting natural products-induced autophagy in
cancer is thought to be too hasty as only least markers were
monitored. For example, it was found that flavokawainB from
Alpha pricei Hayata could increase LC3-EGFP expression
in HCT116 cells [41], but it could possibly happen when
lysosome function was simply blocked out, which resulted in
increase of both cellular and membrane forms of LC3. This
was quite often observed in some early studies of other nat-
ural products including honokiol from Magnolia officinalis
[44], celastrol [30], and tanshinone IIA [65]. As onset of intra-
cellular acidic compartments is a marker of autophagy, Rasul
and colleagues monitored magnolol-induced autophagy by
staining the acidic vesicular organelle with acridine orange
[49]. While increase of acidic particles is usually observed
during induction of autophagy, the lysosome protease activity
may be regulated independently to autophagy process. In this
case, it is still preliminary to draw a conclusion that it was
a real autophagy induced in magnolol-treated cells. In some
cases, it was found that natural productsmay initiate the onset
of autophagy but block the offset process. Rasul et al. men-
tioned that matrine may trigger conversion of LC3 to form
autophagosome; however, the degradation of autophagosome
was impaired as protease activity of lysosome was blocked
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due to elevated lysosomal pH values in matrine-treated cells
[49].Therefore, conclusion could not be simply drawnby only
determining the conversion of LC3. Markers that monitor
the offset of autophagy, such as degradation of p62/SQSTM1,
should be employed in parallel.The turnover of p62/SQSTM1
is massively operated by lysosome during autophagy; as a
result, reduced expression of p62/SQSTM1may bemonitored
as a marker of autolysosome degradation [106]. It was found
that oblongifolin C from Garcinia yunnanensis Hu could
induce the number of autophagosomes; however, blockade
of lysosome function was found and p62/SQSTM1 turnover
was impaired. In this case, whether oblongifolin C could
initiate autophagy remains uncertain and requires further
investigation [14]. Mei et al. considered autophagy in such
a case was aberrant, as study from the research group
showed that gambogenic acid could induce accumulation of
autophagosome but disrupt p62/SQSTM1 degradation [43].
In addition, natural products-stimulated autophagy should
be blocked when pharmacological or genetic inhibitors are
present. Practice was made by Lin et al. to monitor baicalin-
induced autophagy in bladder cancer cells. Besides autophagy
markers were monitored, and cotreatment of 3-MA reduced
autophagy initiation by baicalin [24]. Presence of 3-MA
helps much in identification of autophagy triggered by
natural products, though it could be observed that long-term
treatment of 3-MA with natural products such as celstrol
controversially increased formation of autophagosome [31].
Genetic inhibition using RNA interference against genes
essential for autophagy induction, like Atg5, Atg7, and Atg12,
may be required in parallel to confirm a real autophagy
is induced. Guidelines for autophagy monitoring and data
interpretation are available, which provide comprehensive
and restricted methods in evaluating autophagy [107]. It
is quite good if all the studies on natural products could
strictly follow the guidelines, but the least requirements in
identifying autophagy triggered by natural products could be
the following: (i) formation of autophagosome: this includes
conversion of LC3 from cytoplasmic form tomembrane form
and increase of autophagic flux; (ii) degradation of autolyso-
some: it could be illustrated as elevated acidic compartments
and turnover of p62/SQSTM1; (iii) induction of autophagy
by natural products could be blocked by the presence of
pharmacological inhibitors or RNA interference.
3.2.DoesOrigin of CancerCellsMatter? As a cellular response
mechanism to internal and external stress, autophagy is
regarded as robust but highly conserved across different
types of cells including tumor cells [108]. The regulation
of natural products on autophagy in different cancer cell
lines originated from various tumor tissues should be con-
sistent in this regard. Curcumin was reported to initiate
autophagy in tumor cells from a variety of cancers includ-
ing glioma [34], myeloid leukemia [35], glioblastoma [36],
uterine leiomyosarcoma [37], and lung carcinoma [38]. It was
observed that curcumin could also induce autophagy in colon
cancer stem cells, indicating curcumin-provoked autophagy
is highly consistent and conserved in nondifferentiated cells
as well as well differentiated tumor cells [109]. However,
the role of autophagy in determining fate of cancer cells
treated with natural products may vary across different types
of tumor. It was noticed that bufalin from toad venom
is a potent stimulator of autophagy in various types of
cancers; nonetheless, bufalin-induced autophagy may play
opposite roles in regulating cell death according to results
reported by different research groups. It may be due to
the technical variations; however, we cannot rule out the
influence from genetic variations across different tumor cells,
especially when apoptosis is stimulated along with autophagy
in natural products-treated cells. Compared with autophagy,
apoptosis is under quite restricted control that involves
a series of molecules with proapoptotic or antiapoptotic
functions.These proteins may be aberrantly expressed due to
mutation on cell genome, which results in acquired resistance
against acquired apoptosis in cancer cells [110]. Variation of
genetic mutations across cancers with different origins leads
to various response to natural stimulators of apoptosis. In this
case, the role of autophagy in determining cell fate may differ
accordingly. The way of apoptosis resistance in influence
of the outcome of autophagy may be too complicated to
well illustrate currently; however, it was found that, in
extreme condition when apoptosis is totally defective, natural
products-induced autophagy is mostly contributing to death
of tumor cells. It was also noticed that, in noncancerous
cells that are sensitive to apoptosis stimulators, acquired
autophagy always plays a cytoprotective role to prevent cell
death. Taken together, it may indicate the pivot of switch
between cytoprotective and cytotoxic role of autophagy may
locate at the center of the scale of resistance against apoptosis.
3.3. Is Focus on Signaling PathwaysThat Important? Retrieved
studies have revealed that a single natural product may
regulate multiple signaling pathways in cancer cells that
could mediate onset of autophagy. Expression of molecules
that are directly involved in autophagosome formation, such
as Beclin-1, Atg5, Atg7, Atg12, and LC3, was altered upon
exposure of the compounds as reported by some studies;
however, literature majorly focused on signal transduction
through various pathways of kinase like Akt/mTOR, Erk1/2,
p38 MAPK, AMPK, and JNK. It was shown that some of
these pathways might be responsible for the induction of
autophagy. Kim et al. found that blockade of JNK pathway
by specific inhibitor SP600125, Samsoeum (SEE), extract-
triggered autophagy could be attenuated via suppression on
expression of autophagy-related proteins Beclin-1 and LC3
[62]. Nonetheless, in most of studies, it is still difficult to
clarify if the pathways are actually responsible for autophagy
initiation or just a bypass mechanism that occurs in parallel
with autophagy. A herbal extract named KIOM-C was found
to activate JNK, which seemed to play a role in generating
cellular oxidative and ER stresses in KIOM-C-treated cells
[47]. Autophagy was observed in KIOM-C-treated cells;
however, it was likely that the initiation of autophagic fluxwas
a spontaneous response to oxidative and ER stress in cancer
cells, as there was no evidence to show that autophagy was
involved in KIOM-C-induced cell death. Autophagy might
be the consequence of stress and was independent of the
action of KIOM-C. Neoalbaconol from Albatrellus confluens
could block the consumption of glucose and ATP generation
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of cancer cells, as reported by Deng and colleagues, and
was able to initiate autophagy. Autophagy is a spontaneous
response to energy deprivation in cancer cells [52].Therefore,
signaling transduction induced by natural products is not
likely sufficient for autophagy induction, while in cells where
autophagy is not responsible for cell death or survival upon
natural compounds treatment, autophagymay be regarded as
a consequence of changes on other cellular activities induced
by natural product treatment [32].
However, study on signaling pathway involved in natural
product-induced autophagy may still have significance in
elaborating the action of mechanism. For instance, it was
found, in different studies, bufalin from Chan-su exhibits
both tumor suppressive and cytoprotective autophagy in
human cancer cells. The controversial actions of bufalin
may be due to the differential effect in inducing changes of
signaling pathways. When bufalin was given at lower dose,
it may cause endoplasmic reticulum stress, which would
initiate autophagy to disposemisfolded proteins, and bufalin-
induced autophagy at this dose may elicit protective role to
prevent cancer cells from ER stress-induced apoptosis [28,
111]; while the dose goes higher, autophagymay be excessively
induced, and cancer cell would undergo autophagic cell
death upon treatment of higher dose of bufalin [27, 80].
The differential activation of ER stress-related signaling may
mediate switch of the role of autophagy from cytoprotection
to cytotoxicity and PERK/eIF2𝛼/CHOP was responsible for
the interplay between apoptosis and autophagy in bufalin-
treated cancer cells [81]. Similar conclusion could be obtained
from studies on resveratrol-induced autophagy in cancer
cells. Collectively, study on signaling pathway fosters great
significance in elaborating the role and action of autophagy.
However, as the technical inconsistence was wildly observed,
conclusion derived from these investigationsmay not be con-
vincing enough to illustrate the exact relationship between
action of autophagy and the involved signaling pathway.
More comprehensive and consistent studies are therefore
expected.
3.4. Cytotoxic or Cytoprotective? The Cellular Mechanism.
Autophagy could be either tumor promoting or tumor
suppressive. The tumor suppressive effect may be much
more clear, as autophagy may facilitate cell cycle arrest
and apoptosis or directly induce cell death. The cellular
events in cytoprotective action, in which autophagy helps
cancer cell to overcome various cellular stresses, are not
clearly elucidated in most of the publications. Recycling of
nonessential proteins and organelles to overcome the lack
of substrates of metabolism that are required for survival of
cancer cells under nutrient deprivation may be possibly one
of the major cellular events that fosters the cytoprotective
action of autophagy. In some of the studies, researchers
observed natural products could suppress mTOR pathway,
which was considered as a major mechanism in inducing
autophagy. In fact, mTOR signaling mediated translational
control of protein synthesis and high activity of mTOR
signaling in cancer cells was found in different types of
cancer cells. mTOR inhibition is in this case not just the
way mediating activation of autophagy but an indicator that
cancer cell is trying to overcome nutrient deprivation by
restricting nascent protein synthesis. Autophagy induction
may subsequently contribute to overcoming nutrient depri-
vation by future recycling the existing proteins. However, due
to technical limit in most of the published studies, direct
evidence of natural product-induced autophagy in facilitating
recycling of cellular substrates in nutrient-depriving cancer
cells is not yet available. Moreover, lack of nutrient and
oxygen supply, as well as cytotoxic agent treatment, may lead
to damage of proteins and organelles in cancer cells, which
brings stress to endoplasmic reticulum and mitochondria.
The malfunction of endoplasmic reticulum and mitochon-
dria results in release of proapoptotic factors and causes
subsequent cancer cell death. The induction of autophagy
by natural products may collectively dispose the damaged
proteins and organelles and therefore normalize endoplasmic
reticulum and mitochondria function. It was recently shown
that blockade of autophagy in bufalin-treated HCC cell
could potentiate apoptosis, indicating that bufalin-induced
autophagy may be involved in normalizing endoplasmic
reticulum [111]. Unfortunately, direct evidence in describing
the role of natural product-induced autophagy to stabilize
endoplasmic reticulum and mitochondria in cancer cells is
not yet available in most of published studies. It is expected
in future studies researchers can seek to explore the cellular
events occurring in natural product-induced autophagy,
which makes elucidation on action of autophagy in a more
mechanistic way.
3.5. Crosstalk with Apoptosis by Natural Product-Induced
Autophagy. As a homeostatic process that responds to cellu-
lar stress, autophagy is essential in preventing stress-induced
DNA damage and genomic instability [112]. Despite the
fact that some previous studies have shown that disruption
of autophagy may lead to tumorigenesis, the induction
of autophagy in cancer cell may play more complicated
roles. While autophagy may counteract the natural product-
induced cell death by removing misfolded proteins and
damaged organelle to attenuate cellular stress [113], it was also
noticed that autophagy initiationmay contribute to apoptosis
induced by natural products, as evidenced by reduced antitu-
mor action of the compounds when autophagy was blocked.
In this case, natural product-induced autophagy is considered
a double-edged sword in determining cell fate of human
cancers, and interplay between autophagy and apoptosis is
recently highlighted in this field of study. Several proteins
and signaling pathway may act as scaffold in mediating the
crosstalk of autophagy and apoptosis, including p53, Bcl-
2 family, DAPK, and JNK [114]. It was particularly noticed
that Bcl-2 protein is extensively studied in natural product-
induced autophagy and apoptosis. Bcl-2 may interact with
both autophagy inducer Beclin-1 and proapoptotic factor
Bax to block their function. A series of natural products,
such as curcumin, berberine, and evodiamine, was shown
to block the interaction between Bcl-2 and beclin-1/Bax and
therefore results in autophagy and apoptosis initiation. In
addition, activation of JNK pathway was widely observed
across various studies that focused on anticancer natural
products. As a stress responding pathway, JNK could disrupt
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the inhibition of Beclin-1 by phosphorylating BIM or Bcl-
2. This not only activates beclin-1-dependent autophagy, but
also promotes apoptosis by releasing proapoptotic proteins
due to the inactivation of Bcl-2.The role of p53 and DAPK in
natural product-induced autophagy is not fully revealed, but
Wang et al. found that fangchinoline could lead to nuclear
translocation of p53, which subsequently activated sestrin2
transcription and initiated autophagic cell death inHCC [40].
These studies revealed that the interplay molecules, which
mediate both autophagy and apoptosis activation, may be
effective targets in developing cancer killing agents, though
the function of autophagy induced still requires critical
examination case by case.
4. Direction of Future Study
4.1. In Vivo Monitoring of Autophagy. The property that
natural products could suppress cancers in animal models
is quite important for evaluating the druggability of the
compounds. More and more autophagy-inducing natural
compounds exhibit potent inhibition on tumor growth in
vivo.However, although the role of autophagy in determining
cancer cell fate could be elaborated on in vitro platform,
so far no study could provide compelling evidence showing
that in vivo tumor inhibition of natural products involves its
regulation on autophagy. This may be due to lack of useful in
vivo animal models in which autophagy could be selectively
monitored. He and Klionsky reported in vivo monitoring
of autophagy in a transgenic GFP-LC3 zebrafish line [115].
Induction of autophagy in zebrafish could be viewed by
microscopy in real-time scale. As the approach is simple and
noninvasive, the zebrafish model may be quite suitable for
high throughput screening of natural products that could
initiate autophagy in vivo. However, the model is not disease-
related in nature. Studies by Tian et al. developed transgenic
mice line expressing GFP-LC3, and the role of autophagy
in the pathologic progress of neurological diseases could be
monitored by live imaging technology [116, 117]. This suc-
cessfully established GFP-LC3 transgenic mice which may be
applied to elaborate the role of autophagy in carcinogenesis;
however, monitor of tumor growth over inner organ may
not be available without invading operation. Orthotropic
implantation of tumor cells expressing firefly luciferase has
been established by our colleagues, to provide a real-time,
noninvasive monitoring system on in vivo growth of tumor
[118]. Based on this animal model, a dual-bioluminescent
reporting system could be taken into consideration in which
autophagy as well as tumor growth would be monitored.
The Renilla luciferase reporter is the alternative to firefly
system and is able to yield reliable results. A previous study
has constructed a Renilla luciferase vector-expressing rat
LC3 (pRL-rLC3) which demonstrated the possibility and
reliability of using pRL-rLC3 tomonitor autophagy induction
in cell model [119]. Quenching of Renilla luciferin signal
would be therefore observed if a treatment could induce
autophagy. This hypothesized model may be suitable for
monitoring the role of autophagy in the suppression of tumor
growth by natural products.
4.2. The Synergistic Action of Autophagy-Inducing Natural
Products. In recent years, many reviews have summarized
the synergistic action of natural product in cancer treat-
ment. Many autophagy-inducing natural products, including
berberine, curcumin, and resveratrol, could enhance the
therapeutic effect of other agents, and this synergistic effect
is correlated with induction of autophagy. Peng et al. found
that berberine could enhance tumor-killing action of irra-
diation by inducing autophagic cell death [120]; curcumin
was found to sensitize cancer cells towards treatment of 7-
deoxypancratistatin, a novel chemotherapeutic agent [121];
resveratrol-initiated autophagy enhances the cytotoxicity of
arsenic oxide on primitive leukemic progenitors, indicating a
positive role of autophagy induction in the combination treat-
ment of arsenic oxide and resveratrol against leukemia [122].
The enhancing action of natural products-induced autophagy
could also be observed in some herbal extracts including
Koelreuteria henryi Dummer and Emblica officinalis [123,
124]. These studies have shed light on elucidating the mecha-
nistic role of autophagy in mediating the synergistic action
of natural products in cancer treatment. In fact, there are
still a lot of autophagy-inducing natural products which
have been revealed for their capacity of enhancing antitumor
action of chemotherapy and radiotherapy; however, the role
of autophagy has not yet been fully elucidated. Future study is
highly expected to focus on this property of natural products
and hopefully the contribution of autophagy in combination
therapy could be illustrated inmoremechanistic and clinical-
relevant approaches.
4.3. The Clinical Significance of Autophagy. The ultimate
goal of mentioned studies remains to discover autophagy-
inducing natural products with significant clinical efficacy in
cancer treatment. However, rare published study has focused
on clinical trials of autophagy-inducing natural products. In
fact, the clinical role of autophagy in cancer treatment is not
yet fully elucidated. However, from the data we collected,
it is easy to find some compounds may have been used in
some countries as anticancer agents. For example, bufalin
injection has been used clinically in some parts of China
and has shown some therapeutic action in restricting tumor
progression in cancer patients. A phase I pilot study showed
that bufalin treatment in HCC patients leads to no significant
dose-limiting toxicity and improvement of quality of life
[125]. Some natural products may exhibit potential of clinical
use; for instance, resveratrol, a natural compound universally
present in edible and medical plants, has been considered
chemopreventive in some previous studies. Phase I clinical
trials have been conducted in healthy volunteers, and it
was found that consumption of resveratrol did not cause
serious adverse effects [126]. However, resveratrol can reg-
ulate carcinogen-metabolizing enzymes in human subjects,
which can be the mechanism of its chemopreventive action
as well as the cause of potential herbal-drug interaction
[127]. Clinical study showed that resveratrol alone or in
combination with chemotherapeutic agents has beneficial
effect on cancer patients [128, 129]. This observation sheds
light on the clinical use of resveratrol in treating cancer.
Unfortunately, no available information has been disclosed
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to define the relationship between autophagy and the clinical
action of these natural products.
5. Conclusion
As a conclusion, recent studies have remarked that autophagy
in human cancer cells could be initiated by natural com-
pounds and extracts isolated from anticancer medical plants.
Induction of autophagy by natural products may con-
tribute to its tumor suppressive effect by causing cell senes-
cence, inducing apoptosis-independent death, and provoking
apoptotic death. Natural products-induced autophagy can
also be cytoprotective and cause resistance of cancer cells
against death. Higher technical requirement on monitoring
autophagy in natural products-treated cancer cells is required
to improve study quality in this field. In vivo action of
autophagy in mediating tumor regression may be necessary
to explore in the future, and significance of synergistic action
and clinical relevancy in future studies should be highlighted.
Studies in this field will shed light on the development of lead
compounds of anticancer drug from autophagy-inducing
natural products.
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